Literature DB >> 18990327

Immune reconstitution inflammatory syndrome and human immunodeficiency virus-associated myocarditis.

Jonathan S Rogers1, Sammy Zakaria, Kerry A Thom, Kristin M Flammer, Mettassebia Kanno, Mandeep R Mehra.   

Abstract

Myocarditis is a well-recognized cardiac manifestation of human immunodeficiency virus (HIV) infection, and alterations in the immune system likely play an important role in the pathogenesis of heart muscle disease in HIV-infected patients. Highly active antiretroviral therapy (HAART) has greatly improved survival in HIV patients but not without uncovering new and unique manifestations of disease. Immune reconstitution inflammatory syndrome is a collection of inflammatory disorders in which a pathologic inflammatory response and clinical deterioration occur during recovery of the immune system after HAART. To our knowledge, a correlation between immune reconstitution inflammatory syndrome and HIV-associated myocarditis has not been described previously. We report a case of acute myocarditis presenting with refractory ventricular arrhythmias in a patient with AIDS who experienced rapid immune recovery with the initiation of HAART. The case underscores the importance of recognizing this potential complication of AIDS treatment and calls for renewed vigilance concerning cardiac manifestations of HIV, especially during the immune reconstitution phase.

Entities:  

Mesh:

Year:  2008        PMID: 18990327     DOI: 10.4065/83.11.1275

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  7 in total

1.  Contribution of the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic to de novo presentations of heart disease in the Heart of Soweto Study cohort.

Authors:  Karen Sliwa; Melinda J Carrington; Anthony Becker; Friedrich Thienemann; Mpiko Ntsekhe; Simon Stewart
Journal:  Eur Heart J       Date:  2011-11-01       Impact factor: 29.983

2.  Isothiocyanates ameliorate the symptom of heart dysfunction and mortality in a murine AIDS model by inhibiting apoptosis in the left ventricle.

Authors:  Jin-Nyoung Ho; Ho-Geun Yoon; Chang-Soo Park; Sunoh Kim; Woojin Jun; Ryowon Choue; Jeongmin Lee
Journal:  J Med Food       Date:  2012-09       Impact factor: 2.786

3.  Tissue-specific HIV-1 infection: why it matters.

Authors:  Maile Ay Karris; Davey M Smith
Journal:  Future Virol       Date:  2011-07       Impact factor: 1.831

4.  Myocarditis in CD8-depleted SIV-infected rhesus macaques after short-term dual therapy with nucleoside and nucleotide reverse transcriptase inhibitors.

Authors:  Lakshmanan Annamalai; Susan V Westmoreland; Heber G Domingues; Dennis G Walsh; R Gilberto Gonzalez; Shawn P O'Neil
Journal:  PLoS One       Date:  2010-12-23       Impact factor: 3.240

5.  Pericardial effusion of HIV-infected patients ? Results of a prospective multicenter cohort study in the era of antiretroviral therapy.

Authors:  Alexander Lind; N Reinsch; K Neuhaus; S Esser; N H Brockmeyer; A Potthoff; S Pankuweit; R Erbel; B Maisch; T Neumann
Journal:  Eur J Med Res       Date:  2011-11-10       Impact factor: 2.175

6.  Heart failure and cardiogenic shock associated with the TB-immune reconstitution inflammatory syndrome.

Authors:  Chris Kenyon; Neshaad Schrueder; Mpiko Ntsekhe; Graeme Meintjes
Journal:  Cardiovasc J Afr       Date:  2012-04-12       Impact factor: 1.167

Review 7.  Cardiac effects in perinatally HIV-infected and HIV-exposed but uninfected children and adolescents: a view from the United States of America.

Authors:  Steven E Lipshultz; Tracie L Miller; James D Wilkinson; Gwendolyn B Scott; Gabriel Somarriba; Thomas R Cochran; Stacy D Fisher
Journal:  J Int AIDS Soc       Date:  2013-06-18       Impact factor: 5.396

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.